"Carcinoma, Lobular" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A type of BREAST CANCER where the abnormal malignant cells form in the lobules, or milk-producing glands, of the breast.
| Descriptor ID |
D018275
|
| MeSH Number(s) |
C04.557.470.200.025.305 C04.557.470.615.305 C04.588.180.437 C17.800.090.500.437
|
| Concept/Terms |
Carcinoma, Lobular- Carcinoma, Lobular
- Carcinomas, Lobular
- Lobular Carcinoma
- Lobular Carcinomas
|
Below are MeSH descriptors whose meaning is more general than "Carcinoma, Lobular".
Below are MeSH descriptors whose meaning is more specific than "Carcinoma, Lobular".
This graph shows the total number of publications written about "Carcinoma, Lobular" by people in this website by year, and whether "Carcinoma, Lobular" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 2 | 2 |
| 2000 | 1 | 1 | 2 |
| 2004 | 1 | 0 | 1 |
| 2006 | 0 | 1 | 1 |
| 2008 | 0 | 2 | 2 |
| 2009 | 2 | 1 | 3 |
| 2010 | 2 | 2 | 4 |
| 2011 | 1 | 0 | 1 |
| 2012 | 2 | 0 | 2 |
| 2013 | 2 | 2 | 4 |
| 2014 | 4 | 2 | 6 |
| 2015 | 7 | 0 | 7 |
| 2016 | 2 | 0 | 2 |
| 2017 | 3 | 1 | 4 |
| 2018 | 2 | 1 | 3 |
| 2019 | 0 | 2 | 2 |
| 2020 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
| 2026 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Carcinoma, Lobular" by people in Profiles.
-
American Society of Breast Surgeons, Society of Breast Imaging, and College of American Pathology 2026 Guidelines for the Management of Proliferative Lesions With Atypia and Lobular Carcinoma In Situ. JAMA Surg. 2026 10 01; 161(10):1076-1083.
-
Predictors and outcomes of cutaneous metastatic breast carcinoma: a retrospective, single-institution review. Arch Dermatol Res. 2023 11; 315(9):2725-2728.
-
Germline Pathogenic Variants in Cancer Predisposition Genes Among Women With Invasive Lobular Carcinoma of the Breast. J Clin Oncol. 2021 12 10; 39(35):3918-3926.
-
Feasibility Study of a Novel Protease-Activated Fluorescent Imaging System for Real-Time, Intraoperative Detection of Residual Breast Cancer in Breast Conserving Surgery. Ann Surg Oncol. 2020 Jun; 27(6):1854-1861.
-
Are we Overtreating Hormone Receptor Positive Breast Cancer with Neoadjuvant Chemotherapy? Role of OncotypeDx® for Hormone Receptor Positive Patients Undergoing Neoadjuvant Chemotherapy. Ann Surg Oncol. 2019 Oct; 26(10):3232-3239.
-
Identification and Preservation of Arm Lymphatic System in Axillary Dissection for Breast Cancer to Reduce Arm Lymphedema Events: A Randomized Clinical Trial. Ann Surg Oncol. 2019 Oct; 26(11):3446-3454.
-
The Association of Extent of Axillary Surgery and Survival in Women with N2-3 Invasive Breast Cancer. Ann Surg Oncol. 2018 Oct; 25(10):3019-3029.
-
A Predictive Model for Axillary Node Pathologic Complete Response after Neoadjuvant Chemotherapy for Breast Cancer. Ann Surg Oncol. 2018 May; 25(5):1304-1311.
-
Patient-Reported Outcomes following Breast Conservation Therapy and Barriers to Referral for Partial Breast Reconstruction. Plast Reconstr Surg. 2018 01; 141(1):1-9.
-
Lobular carcinoma in situ and invasive lobular breast cancer are characterized by enhanced expression of transcription factor AP-2ß. Lab Invest. 2018 01; 98(1):117-129.